NCT05617495

Brief Summary

In the United States, adolescents experience alarmingly high rates of major depression, and gold-standard treatments are only effective for approximately half of patients. Rumination may be a promising treatment target, as it is well-characterized at the neural level and contributes to depression onset, maintenance, and recurrence as well as predicts treatment non-response. Accordingly, the proposed research will investigate whether an innovative mindfulness-based real-time functional magnetic resonance imaging (fMRI) neurofeedback intervention successfully elicits change in the brain circuit underlying rumination to improve clinical outcomes among depressed adolescents.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
14mo left

Started Apr 2024

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress64%
Apr 2024Jun 2027

First Submitted

Initial submission to the registry

November 1, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

November 15, 2022

Completed
1.4 years until next milestone

Study Start

First participant enrolled

April 10, 2024

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2027

Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

2.8 years

First QC Date

November 1, 2022

Last Update Submit

April 24, 2026

Conditions

Keywords

Real-time fMRI NeurofeedbackMindfulnessRuminationMajor Depressive Disorder

Outcome Measures

Primary Outcomes (2)

  • Within-person Default Mode Network (DMN) Connectivity

    DMN change will be assessed via fMRI from before mbNF.

    Pre-mbNF procedure

  • Within-person Default Mode Network (DMN) Connectivity

    DMN connectivity will be assessed via fMRI from post mbNF. Changes in DMN connectivity following mbNF are anticipated.

    Post-mbNF procedure

Secondary Outcomes (8)

  • Self-Report Depression Symptoms

    Pre-mbNF procedure

  • Self-Report Depression Symptoms

    Immediately Post-mbNF procedure

  • Self-Report Depression Symptoms

    1-month

  • Interviewer-Assessed Depression Symptoms

    Baseline

  • Interviewer-Assessed Depression Symptoms

    1-month

  • +3 more secondary outcomes

Other Outcomes (7)

  • Ecological Momentary Assessment of Depression Symptoms

    Immediately Post-mbNF procedure

  • Ecological Momentary Assessment of Depression Symptoms

    1-month

  • Ecological Momentary Assessment of Rumination

    Immediately Post-mbNF procedure

  • +4 more other outcomes

Study Arms (2)

15-Minute mbNF

ACTIVE COMPARATOR

Participants receiving mindfulness training and 15-minute session of mbNF

Other: Mindfulness + fMRI Neurofeedback

30-Minute mbNF

ACTIVE COMPARATOR

Participants receiving mindfulness training and 30-minute session of mbNF

Other: Mindfulness + fMRI Neurofeedback

Interventions

Prior to neurofeedback, participants will receive 45 minutes of mindfulness training. Participants will then receive mindfulness-based fMRI neurofeedback targeting the default mode network and frontoparietal control network.

Also known as: Mindfulness-based Real-time fMRI Neurofeedback
15-Minute mbNF30-Minute mbNF

Eligibility Criteria

Age13 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Ages 13-18 years-old
  • Written informed assent/consent and parental/guardian permission for 13-17 year-olds or informed consent for 18 year-olds
  • Tanner puberty stage ≥3
  • Meets current diagnostic criteria for MDD
  • English fluency

You may not qualify if:

  • Lifetime history of primary psychotic disorders, bipolar disorder, oppositional defiant disorder, conduct disorder, developmental disorder (e.g., autism), post-traumatic stress disorder, or eating disorders
  • Substance use disorder, moderate or severe in past 6 months
  • Active suicidal ideation with a specific plan
  • History of seizure disorder
  • Medical or neurological illness (e.g., severe head injury)
  • MRI contraindications
  • Current psychotropic medication use other than antidepressant medication
  • Intelligence quotient (IQ) \<80.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Northeastern University

Boston, Massachusetts, 02115, United States

RECRUITING

Columbia University Irving Medical Center

New York, New York, 10032, United States

RECRUITING

Related Publications (1)

  • Bloom PA, Pagliaccio D, Zhang J, Bauer CCC, Kyler M, Greene KD, Treves I, Morfini F, Durham K, Cherner R, Bajwa Z, Wool E, Olafsson V, Lee RF, Bidmead F, Cardona J, Kirshenbaum JS, Ghosh S, Hinds O, Wighton P, Galfalvy H, Simpson HB, Whitfield-Gabrieli S, Auerbach RP. Mindfulness-based real-time fMRI neurofeedback: a randomized controlled trial to optimize dosing for depressed adolescents. BMC Psychiatry. 2023 Oct 17;23(1):757. doi: 10.1186/s12888-023-05223-8.

MeSH Terms

Conditions

Rumination SyndromeDepressive Disorder, Major

Interventions

Mindfulness

Condition Hierarchy (Ancestors)

Gastrointestinal DiseasesDigestive System DiseasesFeeding and Eating DisordersMental DisordersDepressive DisorderMood Disorders

Intervention Hierarchy (Ancestors)

Cognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Central Study Contacts

Randy P Auerbach, PhD

CONTACT

Simryn Molina, BA

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 1, 2022

First Posted

November 15, 2022

Study Start

April 10, 2024

Primary Completion (Estimated)

January 31, 2027

Study Completion (Estimated)

June 30, 2027

Last Updated

April 29, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

De-identified data will be uploaded to the NIMH NDA.

Locations